Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Pediatrix Medical
MD
$2.14B
| $2.47M | ﹤0.01% |
52,962
+20,503
| +63% | +$941K |
|
2602
Valley National Bancorp
VLY
$8.22B
| $2.47M | ﹤0.01% |
219,689
+191,396
| +676% | +$2.31M |
|
2603
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $2.46M | ﹤0.01% |
102,984
+70,684
| +219% | +$1.7M |
|
|
SODA
2604
PUT
DELISTED
SodaStream International Ltd
SODA
| $2.46M | ﹤0.01% |
17,200
-6,200
| -26% | -$746K |
|
2605
Plexus
PLXS
$7.38B
| $2.46M | ﹤0.01% |
42,069
+23,042
| +121% | +$1.41M |
|
|
DISH
2606
CALL
DELISTED
DISH Network Corp.
DISH
| $2.46M | ﹤0.01% |
68,800
+36,700
| +114% | +$1.26M |
|
2607
Strategy Inc
MSTR
$37.6B
| $2.45M | ﹤0.01% |
174,590
+77,760
| +80% | +$1.09M |
|
2608
PUT
A.O. Smith
AOS
$8.45B
| $2.45M | ﹤0.01% |
45,900
-2,100
| -4% | -$123K |
|
2609
KB Home
KBH
$3.45B
| $2.45M | ﹤0.01% |
102,440
+64,006
| +167% | +$1.61M |
|
|
ODP
2610
DELISTED
ODP
ODP
| $2.45M | ﹤0.01% |
76,246
+34,351
| +82% | +$1.03M |
|
2611
Sanmina
SANM
$11.5B
| $2.45M | ﹤0.01% |
88,612
+20,099
| +29% | +$602K |
|
2612
PUT
Vulcan Materials
VMC
$36.6B
| $2.45M | ﹤0.01% |
22,000
+4,300
| +24% | +$499K |
|
2613
The Ensign Group
ENSG
$10.6B
| $2.44M | ﹤0.01% |
68,898
+37,723
| +121% | +$1.31M |
|
|
ATHN
2614
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $2.44M | ﹤0.01% |
18,300
-200
| -1% | -$30K |
|
2615
White Mountains Insurance
WTM
$5.05B
| $2.44M | ﹤0.01% |
2,610
+112
| +4% | +$104K |
|
2616
Gentherm
THRM
$1.26B
| $2.44M | ﹤0.01% |
53,683
+29,885
| +126% | +$1.36M |
|
|
EGN
2617
CALL
DELISTED
Energen
EGN
| $2.44M | ﹤0.01% |
28,300
-33,200
| -54% | -$2.53M |
|
2618
Enanta Pharmaceuticals
ENTA
$397M
| $2.44M | ﹤0.01% |
28,533
+23,078
| +423% | +$2.31M |
|
2619
CALL
GameStop
GME
$8.31B
| $2.44M | ﹤0.01% |
638,400
+76,800
| +14% | +$294K |
|
2620
CALL
Textron
TXT
$15B
| $2.44M | ﹤0.01% |
34,100
-15,400
| -31% | -$1.05M |
|
2621
Sensient Technologies
SXT
$5.58B
| $2.44M | ﹤0.01% |
31,838
+23,781
| +295% | +$1.7M |
|
2622
Wintrust Financial
WTFC
$10.9B
| $2.44M | ﹤0.01% |
28,667
-91,207
| -76% | -$8.12M |
|
|
TWOU
2623
DELISTED
2U Inc
TWOU
| $2.44M | ﹤0.01% |
1,079
-3,114
| -74% | -$7.7M |
|
2624
CALL
Analog Devices
ADI
$188B
| $2.43M | ﹤0.01% |
26,300
+7,300
| +38% | +$701K |
|
|
AYX
2625
DELISTED
Alteryx Inc
AYX
| $2.43M | ﹤0.01% |
42,482
+30
| +0.1% | +$1.53K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.